# AbbVie Inc.: Form 8-K, filed Oct 4, 2023

- Company: [AbbVie Inc.](/companies/abbv.md) (CIK 1551152)
- Form: 8-K
- Filed: 2023-10-04
- Accepted by EDGAR: Oct 4, 2023, 16:11 ET
- Period: 2023-10-04
- Accession: 0001551152-23-000036
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000036/abbv-20231004.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000036/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1551152/000155115223000036/abbv-20231004.htm

Filed Oct 4, 2023.
Source: SEC EDGAR, the filing index for accession 0001551152-23-000036. Last ingested by Listed: Nov 13, 2026, 16:34 ET. No prices; not investment advice.
